Revvity (RVTY) To Report Earnings Tomorrow: Here Is What To Expect
Revvity (NYSE: RVTY) will report earnings Tuesday before the bell. The company missed last quarter’s revenue expectations with $686.9 million, up 9.3% YoY, and also fell short on full-year revenue guidance and EPS. For the upcoming quarter, analysts expect 3.9% YoY revenue growth. The average analyst price target is $117.13 vs $112.52.
How this was made
The 30-second read
Why it matters
Traders can use the pre-bell timing and the stated consensus growth rate to position for a volatility event, but the article lacks fresh, decision-grade disclosures like new guidance, revisions, or a specific earnings estimate change.
Market read
This is a pre-earnings expectations setup for RVTY, with read-across from peers but no new RVTY-specific financial disclosure beyond the earnings timing.
What to watch
The article does not discuss margins, cash flow, or segment-level drivers, which can dominate earnings reactions even when revenue growth is modest.
Background
The piece frames Revvity’s upcoming earnings against a recent pattern of revenue and full-year EPS guidance misses, while noting consensus reconfirmation over the last 30 days.
Ticker impact
Revvity is set to report earnings Tuesday before the bell, with prior-quarter revenue and guidance misses shaping expectations.
High-volatility setup around the pre-bell print; direction depends on whether revenue growth and guidance re-accelerate versus recent misses.
The text provides timing (pre-bell Tuesday) and expectation framing (3.9% YoY revenue growth vs prior decline), but no new guidance or results beyond what is already described.
Market effects
Peers in research tools and consumables (Avantor, Thermo Fisher) are cited as read-across signals, implying investors may benchmark RVTY against segment trends.
Limited; this is company-specific earnings timing with no explicit regional macro linkage.
Limited; no global policy, supply chain, or regulatory developments are disclosed.
Counterpoint
If RVTY’s revenue growth rate (3.9% YoY expected) holds and guidance stabilizes, the stock could outperform despite the history of misses.
Key entities
- companyRevvity
Life sciences company scheduled to report earnings Tuesday before the bell; prior quarter included revenue and guidance misses.
- companyAvantor
Peer cited as having posted flat YoY revenue and a beat, with shares up after results.
- companyThermo Fisher Scientific
Peer cited as having reported revenue up 10.5% and beating estimates, with shares up after results.
